Method Sign up free

Borrower record · Q2 2026

IVX Health Merger Sub

As filed by Crescent Capital BDC, Inc. · period end 30 June 2026No sector — one filer, nothing to corroborate

Crescent Capital BDC, Inc. is the only BDC lending to IVX Health Merger Sub: $29.2m across three positions at Q2 2026, marked at 114.5 cents. The filer carries it 15 cents above cost.

Filed fair value
$29.2m
3 funded positions
Aggregate mark
114.5c
cost filed on all 3 positions
Maturities to
2030
one date, 1 June 2030
Periods on record
5
Q1 2026 → Q2 2026

How this total is counted

Pricing as filed

2 floating tranches · SOFR

500bp on all 2 floating tranches — every filer reports the same spread.

2 tranches carry an index floor of 1%.

Capital structure

First-Lien Senior Secured2 positions
$23.8m
81.8%
Equity/Other1 position
$5.3m
18.2%

All 3 funded positions carry a filed seniority.

Rate structure

Floating, on all 2 positions whose interest type a filer disclosed.

1 of 3 funded positions carries no filed interest type.

Maturity profile

2 of 3 funded positions dated
2030
$23.8m

3.9 years to maturity, weighted by fair value across the 2 dated positions.

Filed over time

2 periods · aggregate only

Filed fair value

$28.0m
Q1 2026
$29.2m
Q2 2026

Aggregate marknot to zero

109.8c
Q1 2026
114.5c
Q2 2026

Q1 2026, Q2 2026 — every filer reporting the borrower at each period, aggregated. No lender is separated out at any period.

Credit flags

The filer reports no position on non-accrual, and no filed tranche pays in kind.

Not in the filings

Sign up for free

Tell me when this changes.

One lender reports IVX Health Merger Sub today. We will email you when a second one does, when Crescent Capital BDC, Inc.'s mark moves, or when the position leaves the schedule.

Every filing behind this page

1 filer · Q2 2026
FilerCIKFormPeriodFiledAccession
Crescent Capital BDC, Inc. (CCAP)000163333610-Q2026-06-302026-08-100001193125-26-342351

Related borrowers

Same lender